RxSight 2025 Q3 Earnings Net Loss Widens 54.9% Despite Revenue Beat

Thursday, Nov 6, 2025 9:14 pm ET1min read
RXST--
Aime RobotAime Summary

- RxSightRXST-- (RXST) reported Q3 2025 earnings with a 54.9% wider net loss despite $25.69M in Light Adjustable Lens (LAL) sales.

- Revenue growth was offset by a 68% plummet in LDD unit sales to 25 and persistent operational challenges.

- Post-earnings stock volatility and a maintained "Hold" rating highlight ongoing risks despite revenue outperformance.

RxSight (RXST) reported Q3 2025 earnings on November 6, 2025, . . However, , , underscoring ongoing financial challenges.

Revenue

Light Adjustable Lens (LAL) sales led with $25.69 million, . Service-related revenue, including warranties and accessories, , . , driven by a 68% drop in LDD units sold to 25.

Earnings/Net Income

, . , . , signaling persistent operational headwinds.

Price Action

.

Post-Earnings Price Action Review

, . However, , highlighting risks tied to market volatility. This suggests potential for gains but underscores the need for caution.

CEO Commentary

, . .

Guidance

, , . .

Additional News

, , while maintaining a Hold rating. , , , , .

Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet